Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast Cancer

NCT03121352 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Triple Negative Breast Cancer

Interventions

DRUG: Carboplatin
DRUG: Nab-paclitaxel
DRUG: Pembrolizumab

Sponsor

Case Comprehensive Cancer Center